Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Gensight Biologics SA

Start price
Target price
Perf. (%)
€2.97
07.03.22
-
07.03.23
-19.53%
08.03.23

Risky Investment
Lokrim 
07.03.22 20%
sell
Innate Pharma

Start price
Target price
Perf. (%)
€2.51
07.03.22
-
07.03.23
21.39%
08.03.23

Probably not worthwhile Investment
Lokrim 
07.03.22 20%
sell
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€2.21
05.03.22
€1.00
05.03.23
35.37%
19.03.22

mixitrader 
05.03.22 50%
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€2.99
03.03.22
-
03.03.23
-5.52%
04.11.22

Bankster 
03.03.22 50%
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€39.16
23.02.22
-
23.02.23
-33.30%
13.08.22

Trip 
23.02.22 50%
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€3.04
20.02.22
€4.00
20.03.22
-11.39%
21.03.22

Could be worthwhile Investment >10% per year
melinda 
20.02.22 50%
buy
Sartorius Stedim Biotech S.A.

Start price
Target price
Perf. (%)
€328.00
20.02.22
€400.00
20.02.23
1.01%
21.02.23

Could be worthwhile Investment >10% per year
melinda 
20.02.22 50%
buy
Innate Pharma

Start price
Target price
Perf. (%)
€3.01
19.02.22
€4.00
19.02.23
-11.75%
05.03.22

metanicnor 
19.02.22 60%
sell
Korian S.A.

Start price
Target price
Perf. (%)
€17.76
19.02.22
€16.00
19.02.23
1.18%
05.03.22

metanicnor 
19.02.22 50%
sell
Orpea Nom.

Start price
Target price
Perf. (%)
€36.36
19.02.22
€32.00
19.02.23
-5.42%
05.03.22

Risky Investment
metanicnor 
19.02.22 50%
buy
Valbiotis

Start price
Target price
Perf. (%)
€6.09
19.02.22
-
19.02.23
-18.39%
05.10.22

Could be worthwhile Investment >10% per year
melinda 
19.02.22 20%
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€4.07
15.02.22
€5.00
15.03.22
-25.36%
20.02.22

Could be worthwhile Investment >10% per year
melinda 
15.02.22 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€14.84
15.02.22
-
15.02.23
0.61%
20.02.22

bundfuture 
15.02.22 50%
buy
Innate Pharma

Start price
Target price
Perf. (%)
€3.24
10.02.22
€3.80
10.02.23
-4.81%
11.02.23

Could be worthwhile Investment >10% per year
melinda 
10.02.22 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.03
09.02.22
-
09.03.22
-0.86%
10.03.22

Hydroklaus 
09.02.22 50%
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€31.95
07.02.22
-
07.02.23
-92.57%
08.02.23

Letue35 
07.02.22 0%
buy
Orpea Nom.

Start price
Target price
Perf. (%)
€31.70
07.02.22
-
07.03.22
15.65%
18.02.22

Sievi 
07.02.22 70%
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€91.27
06.02.22
€95.00
06.02.23
1.76%
19.02.22

metanicnor 
06.02.22 60%
sell
Orpea Nom.

Start price
Target price
Perf. (%)
€34.38
06.02.22
€31.00
06.02.23
5.76%
19.02.22

Risky Investment
metanicnor 
06.02.22 60%
sell
Korian S.A.

Start price
Target price
Perf. (%)
€17.69
06.02.22
-
06.02.23
0.40%
19.02.22

metanicnor 
06.02.22 70%
buy
Onxeo S.A.

Start price
Target price
Perf. (%)
€0.40
06.02.22
€0.55
06.02.23
7.30%
07.02.23

metanicnor 
06.02.22 40%
buy
Innate Pharma

Start price
Target price
Perf. (%)
€3.36
06.02.22
€3.70
06.02.23
-10.41%
19.02.22

metanicnor 
06.02.22 60%
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.03
05.02.22
€20.00
05.02.23
-57.41%
06.02.23

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Good culture
Could be very worthwhile Investment >20% year
jobah 
05.02.22 30%
buy
Neovacs

Start price
Target price
Perf. (%)
€25,296
05.02.22
€48,000
05.02.23
-40.54%
19.02.22

nvestor 
05.02.22 50%
buy
Theranexus

Start price
Target price
Perf. (%)
€3.18
04.02.22
€36.00
04.02.23
-41.98%
05.02.23

Could be worthwhile Investment >10% per year
melinda 
04.02.22 50%